Amgen Foundation and Changemakers Launch Global Online Competition to Empower Patients

Amgen Inc.The Amgen Foundation is supporting an online competition with Ashoka's Changemakers to find the best solutions that elevate patients' voices to improve health outcomes globally.

The Patients | Choices | Empowerment competition is seeking solutions that tap the medical experience, knowledge, and wisdom of current and past patients, health care practitioners, advocates and other key stakeholders to ensure that patients have an active role in their personal healthcare. The ideal solutions are those that empower the patient and provide avenues for informed decisions.

"With healthcare a key concern around the globe, the Amgen Foundation hopes the competition will surface solutions that can give patients the knowledge and confidence to participate collaboratively at every stage of their healthcare," said Jean J. Lim, president of the Amgen Foundation.

The competition takes place at www.changemakers.com/empower-patient where visitors can enter the competition, discuss and share ideas related to patient empowerment, comment on entries, and vote for the finalists. Finalists will be selected by an expert panel of judges based on innovation, social impact, and sustainability. Three winners will each be awarded US$10,000. Entries will be accepted until Sept. 29, 2010 and the winners will be announced in December 2010.

"We look forward to seeing the global Changemakers community, including Ashoka's network of social entrepreneurs, collaborate to build a worldwide network of support for patients so they experience better health outcomes," said Sushmita Ghosh, founder and chair of Ashoka's Changemakers. "This competition will encourage participants to innovate and collaborate, form partnerships, and build a movement that empowers patients."

Following the Changemakers competition, selected entries may be invited to submit proposals to the Amgen Foundation for future funding consideration. The Amgen Foundation will consider awarding up to US$1 million in grants to support promising innovations in patient empowerment submitted by qualifying nonprofit organizations.

About Ashoka's Changemakers
Ashoka's Changemakers is a community of action that connects social entrepreneurs around the globe to share ideas, inspire, and mentor each other. Through its online collaborative competitions and open-source process, Changemakers.com is one of the world's most robust spaces for launching, discussing, and funding ideas to solve the world's most pressing social problems. Changemakers builds on Ashoka's three decade history and belief that we all have the ability to be a Changemaker.
www.Changemakers.com

About The Amgen Foundation
The Amgen Foundation (http://www.amgen.com/citizenship/overview.html) seeks to advance science education; improve patient access to quality care; and strengthen the communities where Amgen staff members live and work. Since 1991, the Foundation has made more than $140 million in grants to nonprofit organizations throughout the United States, Puerto Rico, and Europe that impact society in inspiring and innovative ways, and those that provide disaster relief efforts both domestically and internationally.

Most Popular Now

Novo Nordisk announces plans to transform its appr…

Novo Nordisk announced plans to restructure its Research & Development (R&D) organisation to accelerate the expansion and diversification of its pipeline across serious c...

The Merck Accelerator Program 2019

The Merck Accelerator is looking for real partners so that you can work together in shaping the future. With programs in the headquarters in Germany, in China and the Sat...

World's largest Alzheimer's survey reveals most ad…

Amgen (NASDAQ:AMGN), Novartis and Banner Alzheimer's Institute (BAI), in association with Alzheimer's Disease International (ADI), announced results from the largest glob...

Imfinzi is the first immunotherapy to demonstrate …

AstraZeneca and MedImmune, its global biologics research and development arm, have presented data on overall survival (OS) in the Phase III PACIFIC trial of Imfinzi durin...

Pre-clinical success for a universal flu vaccine o…

Researchers from the University of Oxford's Department of Zoology have demonstrated pre-clinical success for a universal flu vaccine in a new paper published in Nature Co...

Discovery could explain failed clinical trials for…

Researchers at King's College London have discovered a vicious feedback loop underlying brain degeneration in Alzheimer's disease which may explain why so many drug trial...

Global survey reveals that physicians need more in…

Results from a new global survey revealed that more than one-third (36%) of the 310 physicians surveyed do not think they have sufficient information required to make inf...

Aspirin found not to prolong healthy aging

Taking a low-dose aspirin daily does not prolong healthy living in older adults, according to findings from the ASPirin in Reducing Events in the Elderly (ASPREE) trial p...

The Lancet Respiratory Medicine publishes first Ph…

AstraZeneca today announced publication of results from the KRONOS Phase III trial which evaluated the efficacy and safety of triple combination therapy PT010 (budesonide...

In clinical trials, new antibody therapy controls …

Thanks to improvements in antiretroviral therapy, HIV is now a manageable condition. Yet even the best drugs do not entirely eliminate the virus, which latently lingers i...

FDA approves first treatment for advanced form of …

The U.S. Food and Drug Administration today approved Libtayo (cemiplimab-rwlc) injection for intravenous use for the treatment of patients with metastatic cutaneous squam...

Clinical gene discovery program solves 30 medical …

A table in a recently published paper tells the story of 30 families who have, sometimes after years of searching, finally received an answer about the condition that has...